About Incannex Healthcare Inc. - Common Stock (IXHL)
Incannex Healthcare Inc. is a biotechnology company focused on developing innovative therapies that harness the potential of cannabinoid-based medicine. The company is dedicated to conducting rigorous clinical research to create safe and effective treatments for a range of medical conditions, including pain, anxiety, and other illnesses. Incannex aims to navigate the evolving regulatory landscape and collaborate with medical professionals to bring cannabinoid solutions to patients, while also emphasizing the importance of scientific validation and patient safety in the pharmaceutical field. Read More
Let's delve into the US markets on Tuesday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
The US market is yet to commence its session on Tuesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Let's have a look at what is happening on the US markets after the closing bell on Wednesday. Below you can find the top gainers and losers in today's after hours session.
As the regular session of the US market concludes on Tuesday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.
FDA approves Incannex's Phase 2 trial for psilocybin-assisted psychotherapy in treating generalized anxiety disorder, following a successful review of the IND application.
Incannex Healthcare Inc., a cannabinoid and psychedelic medicine biotechnology company, announced the successful completion of a pre-investigational new drug meeting with the U.S. Food and Drug Administration (FDA) regarding the development of CannQuit-O for the treatment of opioid use disorder (OUD).A number of FDA representatives shared insights on the CannQuit-O development program during the pre-IND teleconference in addition to providing recommendations on the proposed clinical development strategy.
Psilocybin-assisted therapy shows promise in treating GAD. Denver trains first responders in psychedelic crisis intervention. Heroic Hearts Project supports veterans with PTSD through legal psychedelic therapy. Colorado's Natural Medicine Health Act is a model for integrating psychedelics into public health.
